News and Events

Hatchtech commences 2b clinical trial of new generation head lice treatment DeOvo™

2/05/2011 | Press Releases

Venture-backed pharmaceutical company Hatchtech Pty Ltd has enrolled the first subjects for its Phase 2b clinical study to confirm the efficacy of its novel head lice treatment DeOvo™.

Download PDF


Categories